PATENT CLAIM ANALYSIS

Application Number: 16269628
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "158000"]

Abstract:
This document provides methods and materials involved in treating cardiovascular conditions such as calcific aortic valve stenosis. For example, methods and materials for using sGC agonists or a combination of sGC agonists and PDE5A inhibitors to reduce calcification of heart valves and/or vessels or to slow progression of aortic sclerosis to calcific aortic valve stenosis are provided.

Claim (Index 12):
The method of  claim 9 , wherein said sGC agonist is BAY 41-2272.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 99.0
- Lexical Diversity: 1.39535
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15702461', '14652903', '14861428', '12908467', '12227872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7910792209592462
- 35 USC 102 Novelty (BERT): 0.646076779769874
- Combined Prediction Score: 0.776578976840309
- Mean Citation Score: 387.797056
- Max Citation Score: 640.1366
- Similarity Product: 517.1467166427851

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test